Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer
Alessio Amatu(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Salvatore Siena(University of Milan)
Cited by 300
Related Papers
Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer
|PLoS ONE|2009|257
Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies
|Cancer Immunology Research|2022|73